Antimicrobial susceptibility to β-lactam antibiotics and production of BRO β-lactamase in clinical isolates of Moraxella catarrhalis from a Japanese hospital.

[1]  R. Saito,et al.  Prevalence and molecular analysis of macrolide-resistant Moraxella catarrhalis clinical isolates in Japan, following emergence of the highly macrolide-resistant strain NSH1 in 2011. , 2015, Journal of medical microbiology.

[2]  R. Saito,et al.  Molecular analysis of low-level fluoroquinolone resistance in clinical isolates of Moraxella catarrhalis. , 2014, Journal of medical microbiology.

[3]  R. Saito,et al.  The frequency of BRO β-lactamase and its relationship to antimicrobial susceptibility and serum resistance in Moraxella catarrhalis. , 2014, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[4]  J. Liñares,et al.  Comparison of Restriction Enzymes for Pulsed-Field Gel Electrophoresis Typing of Moraxella catarrhalis , 2013, Journal of Clinical Microbiology.

[5]  T. Ezaki,et al.  Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: general view of the pathogens’ antibacterial susceptibility , 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[6]  Yi-Tsung Lin,et al.  Antimicrobial resistance of Moraxella catarrhalis isolates in Taiwan. , 2012, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[7]  A. van Belkum,et al.  bro {beta}-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults. , 2010, The Journal of antimicrobial chemotherapy.

[8]  Ronald N. Jones,et al.  Development of a Disk Diffusion Method for Testing Moraxella catarrhalis Susceptibility Using Clinical and Laboratory Standards Institute Methods: a SENTRY Antimicrobial Surveillance Program Report , 2009, Journal of Clinical Microbiology.

[9]  S. Richter,et al.  Molecular Characterization of the β-Lactamases from Clinical Isolates of Moraxella (Branhamella)catarrhalis Obtained from 24 U.S. Medical Centers during 1994–1995 and 1997–1998 , 2000, Antimicrobial Agents and Chemotherapy.